Thus, in our study, we were only able to investigate the methylation changes in a small cohort of active BD patients and we neither compared the IRF8 methylation status between active ocular BD patients with or without drug treatment nor correlated the methylation changes with the clinico-pathological features of BD patients. The gene discussed is IRF8; the disease is Behcet disease.